Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Winter;11(Suppl 1):S146-S148.

Single-nucleotide polymorphism of Exo1 gene is associated with risk of colorectal cancer based on robust Bayesian approach

Maryam Nasserinejad  1 , Mohamad Amin Pourhoseingholi  2 , Sama Rezasoltani  1 , Setareh Akbari  2 , Ahmad Reza Baghestani  3 , Sadjad Shojaee  1 , Mohammad Yaghoob-Taleghani  1 , Ehsan Nazemalhosseini-Mojarad  2
Affiliations

Single-nucleotide polymorphism of Exo1 gene is associated with risk of colorectal cancer based on robust Bayesian approach

Maryam Nasserinejad et al. Gastroenterol Hepatol Bed Bench. 2018 Winter.
No abstract available

PubMed Disclaimer

References

    1. Magaji BA, Moy FM, Roslani AC, Law CW. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital. BMC cancer. 2017;17:339. - PMC - PubMed
    1. Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in iran: molecular epidemiology and screening strategies. J Cancer Epidemiol. 2015;2015:643020. - PMC - PubMed
    1. Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FS. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6:S52–7. - PMC - PubMed
    1. Azizmohammad Looha M, Pourhoseingholi MA, Nasserinejad M, Najafimehr H, Zali MR. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran. Epidemiol Health. 2018;40:e2018045. - PMC - PubMed
    1. Nazemalhosseini Mojarad E, Farahani RK, Haghighi MM, Aghdaei HA, Kuppen PJ, Zali MR. Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol Bed Bench. 2013;6:6–13. - PMC - PubMed

LinkOut - more resources